Menopause and Nerve Pain: Why the Burning Starts Twenty Years Later

Frayed beige rope fibers intertwined with swirling colorful light waves

Close-up of a frayed rope entangled with flowing, luminous waves of color

For many women, menopause and nerve pain can become deeply intertwined as they age.

She is seventy-one years old, and her feet are on fire.

It started as a strange buzzing, mostly at night, mostly when the house was quiet. Then came the burning. Then the numbness that somehow coexists with the burning, which makes no sense until you have felt it. She mentioned it once at an appointment. Her blood sugar was checked. It was fine. She was told it was probably just aging.

So she stopped mentioning it.

Here is what nobody told her. Menopause and nerve pain are connected, and the connection does not always announce itself when the hot flashes do. Sometimes it waits…Sometimes it waits two decades.

That delay is not a coincidence. It is a clue.

Your Nerves Were Listening the Whole Time

Estrogen is not a reproductive hormone that happens to affect a few other things. It is a signaling molecule with receptors scattered throughout the body, including in places that have nothing to do with fertility.

Your peripheral nerves are one of those places.

Estrogen receptors are present in the dorsal root ganglia, the clusters of sensory nerve cell bodies that carry sensation from your limbs toward your spinal cord. They are present in Schwann cells, the cells that build and maintain the myelin sheath insulating your nerve fibers. Laboratory research has shown that estradiol promotes Schwann cell proliferation and differentiation and accelerates remyelination after nerve injury. Progesterone appears to support myelin production as well.

Furthermore, estrogen influences how excitable a nerve is in the first place. It affects sodium and potassium channel behavior, which governs whether a nerve fires appropriately or fires spontaneously for no reason at all. It also affects microvascular tone, meaning it helps determine whether your smallest nerves receive adequate blood supply.

Now consider what happens when that signal goes quiet and stays quiet.

The maintenance crew does not vanish overnight. It simply stops getting resupplied. Insulation goes unrepaired. Excitability drifts. Perfusion to the tiniest, most vulnerable fibers thins. Nothing dramatic happens on any given Tuesday.

Then one night, twenty years on, your feet are burning.

Why It Takes Two Decades

This is the part that makes the pattern make sense.

The average woman reaches menopause around fifty-one. Idiopathic small fiber neuropathy, the kind with burning feet and no obvious cause, characteristically presents in patients over sixty. Sit with that arithmetic for a moment. The gap between those two numbers is roughly a decade to two decades, and it is exactly the window these women describe.

Still, the average is only an average. Some women reach menopause much earlier. A woman whose ovaries are surgically removed, a procedure called a bilateral oophorectomy, enters menopause immediately, whatever her age. This is called surgical menopause, and because estrogen falls all at once rather than tapering over years, the change can arrive abruptly and forcefully. Others enter early or premature menopause naturally, or as a result of chemotherapy, radiation, or ovarian conditions. For all of these women, the clock this article describes simply starts sooner. The nerve symptoms may follow the same delayed pattern, arriving a decade or two after that earlier beginning.

Small fiber neuropathy affects the thinly myelinated A-delta fibers and unmyelinated C fibers. Those fibers carry pain, temperature, and autonomic signals. They are also critically the most metabolically demanding and the most fragile. They fail first, and they fail farthest from the center, which is why it starts in the feet and works upward rather than the reverse.

Slow attrition does not look like an event. It looks like nothing, for years, and then it looks like a symptom.

This is why so many women are dismissed. There was no injury, no diagnosis, and no moment anyone could point to. In the absence of an event, the burning gets filed under aging, and the woman gets sent home.

But absence of an event is not absence of a cause. It is the signature of a slow one.

Before You Blame Menopause, Rule Out What Can Harm You

Now I need to say something firmly, and I need you to actually hear it, because this is the part that could protect your life.

Do not let “it must be my hormones” close the file.

Diabetes is the single most common identifiable cause of small fiber neuropathy. More than that, impaired glucose tolerance, the stage before diabetes, is frequently found in women labeled as having idiopathic neuropathy. A normal fasting glucose does not rule this out. It takes a hemoglobin A1c, and often a glucose tolerance test, to see what is actually happening.

Additionally, several other causes deserve a look before anyone shrugs. Vitamin B12 deficiency is common in older adults, common in those taking metformin or acid-reducing medications, and entirely treatable. Thyroid dysfunction matters, since hypothyroidism is a documented cause of small fiber pain. Sjögren’s syndrome, an autoimmune condition that damages small fibers, disproportionately affects women. Celiac disease belongs on the list. So does monoclonal gammopathy, which appears far more often in idiopathic neuropathy than in the general population.

Some of these are simple to correct. One of them, undiagnosed diabetes, will keep damaging your nerves, your kidneys, and your eyes for as long as it goes unnamed and untreated.

So yes, hormones are part of this story. They are not permission to skip the workup. Ask for the A1c. Ask for the B12. If you are brushed off, ask again, and keep asking until your concerns are no longer dismissed.

You are not being difficult. You are being thorough. Also, use logic. Ask: What is the harm?

The Honest Truth About Hormones and Nerve Pain

I am not going to tell you that hormone therapy will fix your neuropathy, because that is not what the evidence says, and I will not sell you hope I cannot back.

Here is the actual state of things.

The mechanistic case is genuinely strong. Estrogen receptors in sensory nerves are real. Estradiol’s effect on Schwann cells and remyelination is documented. Animal models show that removing ovarian hormones worsens neuropathic pain. That is not nothing. It explains why the pattern exists, and it validates women who have been told their symptoms are imaginary.

But mechanism is not proof of treatment. Robust randomized trials showing that systemic hormone therapy resolves established neuropathy in women decades past menopause do not exist. What explains a problem does not automatically reverse it.

There is more, and it matters enormously for the woman I described at the beginning.

Twenty years past menopause is precisely the window in which starting systemic hormone therapy is least favorable. Current FDA labeling guidance recommends initiating systemic therapy within ten years of menopause or before age sixty. A seventy-one-year-old starting estrogen for burning feet, on the strength of remyelination data from animal studies, would be taking on cardiovascular and stroke risk to chase a benefit that has never been demonstrated in someone her age. That is not to say it wouldn’t be an appropriate treatment.

Local vaginal estrogen is a genuine exception, and a meaningful one. Where nerve-related symptoms are genitourinary, meaning burning, urgency, or recurrent infection, that therapy is low dose, minimally absorbed, and appropriate at nearly any age. But it treats the tissue where it is applied. It will not reach your feet.

Truth is kinder than false hope. It just takes longer to feel that way.

What Actually Helps

So where does that leave the woman whose feet are burning at seventy-one or forty-five in early onset menopause?

Not nowhere. Not remotely nowhere.

Start with glucose, because this is the lever with the most evidence behind it and the most power in your hands. Impaired glucose tolerance damages small fibers, and impaired glucose tolerance responds to how you eat. A whole-food, plant-based way of eating improves insulin sensitivity in a way that reaches down to the smallest vessels feeding the smallest nerves. This is not a side note in your healing. For many women, it is the main event.

Next, correct the deficiencies. B12 is inexpensive to test and inexpensive to fix. Thyroid is the same.

Then care for the nerve itself. Movement improves microvascular perfusion, and perfusion is exactly what those starving fibers are missing. Sleep is when repair happens, and neuropathic pain that peaks at night steals precisely the hours you need most. Meanwhile, chronic stress keeps the nervous system in a state of alarm, which lowers your threshold for pain before the pain even arrives.

Finally, pursue real treatment for the pain itself. Legitimate options exist, and your doctor can walk you through them. Suffering quietly is not spiritual maturity. It is just suffering.

Your Body Is Not Lying to You

Twenty years is a long time to be told nothing is wrong.

If you are that woman, hear this. The burning is real. The buzzing is real. The strange numbness that lives right on top of the pain is real. Your body is not manufacturing sensations to inconvenience you. It is reporting something true, and it has been reporting it faithfully to people who were not listening.

YHVH designed a body that speaks. He also designed nerves that need maintenance, hormones that carry the signal, and a woman with the standing to insist that someone look.

You are not too old to be investigated. You are not too late to be helped. And you are not required to accept “it’s just aging” from anyone who has not bothered to run the test.

Go be believed. Then go get the workup.

For the full picture of how this season affects the whole body, this guide to menopause and whole-person wellness covers hormones, symptoms, and healthy aging in one place.

Continue the Journey

Has this article named something you have been carrying? Do not stop here.

If you are ready to understand the layer beneath your symptoms, RISE: Healing From the Inside Out, Volume 3 goes straight into stress, the nervous system, and why your body reacts before your mind catches up.

If you have spent years being told your body was wrong, RISE: Body Trust, Movement, & Mindful Strength, Volume 2 helps you rebuild the relationship. Your body was never the enemy. It was faithful.

If being dismissed has worn down what you believe about yourself, RISE™ Identity & Worth, Volume 1 addresses the beliefs underneath.

If glucose is where your work begins, The Eden Way walks you back to the Creator’s original design for how you eat and how you heal.

Are you looking for the whole framework? RISE: The Beginning of Balance lays the foundation.

And if you need something to hold on the nights the pain will not let you sleep, Psalms of Rooting gives you scripture to return to.

A Reading List for This Journey


More in This Series

If this article spoke to you, it is part of a five-part series on menopause, hormones, and what nobody explained clearly enough. Each one stands alone, but together they tell the whole story.

Even More

You do not have to carry this alone. The RISE with Momentum Circle meets weekly, and you will be believed there.

Pain that goes unnamed does not go away. It only goes unwitnessed.

Healthy Living Picks

Nerve health is built in the kitchen more than most people realize. Over on my Amazon Storefront, I keep a curated collection of the books, kitchen tools, and wellness resources I actually use, including titles on blood sugar, plant-based eating, and nervous system support.

Take a look when you have a quiet moment. Everything there is something I would hand to a friend.

As an Amazon Associate, I earn from qualifying purchases.

References

  1. Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality… JAMA. 2020;324(4):369–380. doi:10.1001/jama.2020.9482. PMID: 32721007. (Cited for the WHI age distribution and timing context.)
  2. Manson JE, Crandall CJ, Rossouw JE, et al. The Women’s Health Initiative randomized trials and clinical practice: a review. JAMA. 2024;331(20):1748–1760. doi:10.1001/jama.2024.6542. PMID: 38691368. (Timing hypothesis; initiation within 10 years of menopause or before 60.)
  3. The North American Menopause Society. The 2022 hormone therapy position statement. Menopause. 2022;29(7):767–794. doi:10.1097/GME.0000000000002028. PMID: 35797481. (Guidance on initiation window and age.)
  4. Sullivan SD, Sarrel PM, Nelson LM. Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril. 2016;106(7):1588–1599. doi:10.1016/j.fertnstert.2016.09.046. PMID: 27912889. (Estrogen’s broader systemic and neural roles.)
  5. Tang B, Ji Y, Traub RJ. Estrogen alters spinal NMDA receptor activity via a PKA signaling pathway in a visceral pain model. Pain. 2008;137(3):540–549. doi:10.1016/j.pain.2007.10.017. PMID: 18068901. (Estrogen modulation of nociceptive signaling — mechanism support.)
  6. Terkawi AS, et al. Development and validation of Arabic version of the neuropathic pain scale; and broader small-fiber neuropathy epidemiology. See: Peters MJH, et al. Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology. 2013;81(15):1356–1360. doi:10.1212/WNL.0b013e3182a8236e. PMID: 24028940. (Small fiber neuropathy epidemiology and age of onset.)
  7. Hovaguimian A, Gibbons CH. Diagnosis and treatment of pain in small-fiber neuropathy. Curr Pain Headache Rep. 2011;15(3):193–200. doi:10.1007/s11916-011-0181-7. PMID: 21286866. (Workup for small fiber neuropathy: glucose tolerance, B12, thyroid, Sjögren’s, celiac, monoclonal gammopathy.)
  8. Smith AG, Singleton JR. Impaired glucose tolerance and neuropathy. Neurologist. 2008;14(1):23–29. doi:10.1097/NRL.0b013e31815a3956. PMID: 18195663. (Impaired glucose tolerance as a cause of small-fiber neuropathy hidden behind normal fasting glucose.)
  9. U.S. Food and Drug Administration. HHS advances women’s health, removes misleading FDA warnings on hormone replacement therapy. FDA news release; November 10, 2025. fda.gov/news-events/press-announcements
  10. Makary MA, Nguyen CP, Høeg TB, Tidmarsh GF. Updated labeling for menopausal hormone therapy. JAMA. Published online November 10, 2025. doi:10.1001/jama.2025.22259

Important Nuances

ACOG applauded the vaginal-estrogen change specifically, but some clinicians and outlets have pushed back that the systemic-estrogen benefits are being overstated and the breast cancer nuance flattened.

The specific claim that idiopathic small fiber neuropathy characteristically presents 10–20 years after menopause is a synthesis of the average menopause age (~51) and the typical SFN age of onset (>60) from refs 6–8, not a single study that tracked that exact interval. It is phrased in the article as an inference.  

The estrogen–Schwann cell/remyelination mechanism is well documented in laboratory and animal work, but, as the article already states plainly, has not been shown in randomized trials to treat established neuropathy in older women. That honesty is a feature of the piece, and the reference list does not imply otherwise.

Related Post

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.